Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2020 $ 16,650 $ 2,622 $ 91,523 $ (1,117) $ (76,378)
Beginning Balance , Shares at Dec. 31, 2020   261,907,622      
Issuance of common stock pursuant to initial public offering 439,556 $ 313 439,243    
Issuance of common stock pursuant to initial public offering, Shares   31,250,000      
Stock-based compensation expense 216,579   216,579    
Vesting of restricted stock units, Shares   7,680      
Issuance of common stock under employee plans 7,830 $ 72 7,758    
Issuance of common stock under employee plans, shares   7,289,354      
Shares repurchased (2,760)   (2,760)    
Shares repurchased, Shares   (334,205)      
Gain on interest rate swap 1,342     1,342  
Net Income (Loss) (22,045)       (22,045)
Ending Balance at Dec. 31, 2021 657,152 $ 3,007 752,343 225 (98,423)
Ending Balance , Shares at Dec. 31, 2021   300,120,451      
Stock-based compensation expense 22,305   22,305    
Vesting of restricted stock units   $ 6 (6)    
Vesting of restricted stock units, Shares   517,422      
Issuance of common stock under employee plans 4,223 $ 4 4,219    
Issuance of common stock under employee plans, shares   463,038      
Exercise of stock options 4,773 $ 55 4,718    
Exercise of stock options, shares   5,525,619      
Gain on interest rate swap 0        
Change in interest rate swap (225)     $ (225)  
Net Income (Loss) 112,900       112,900
Ending Balance at Dec. 31, 2022 801,128 $ 3,072 783,579   14,477
Ending Balance , Shares at Dec. 31, 2022   306,626,530      
Stock-based compensation expense 24,001   24,001    
Vesting of restricted stock units   $ 7 (7)    
Vesting of restricted stock units, Shares   694,100      
Issuance of common stock under employee plans 2,997 $ 4 2,993    
Issuance of common stock under employee plans, shares   434,952      
Exercise of stock options $ 6,779 $ 74 6,705    
Exercise of stock options, shares 7,253,424 7,436,819      
Gain on interest rate swap $ 0        
Net Income (Loss) 80,130       80,130
Ending Balance at Dec. 31, 2023 $ 915,035 $ 3,157 $ 817,271   $ 94,607
Ending Balance , Shares at Dec. 31, 2023   315,192,401